Holen Sie sich die Stockscreener-App
21.63
1.93%
0.41
Schlusskurs vom Vortag:
$21.22
Offen:
$21.26
24-Stunden-Volumen:
2.91M
Relative Volume:
0.86
Marktkapitalisierung:
$3.09B
Einnahmen:
$62.38M
Nettoeinkommen (Verlust:
$-101.59M
KGV:
-25.02
EPS:
-0.8644
Netto-Cashflow:
$-139.93M
1W Leistung:
+8.91%
1M Leistung:
+87.60%
6M Leistung:
+181.27%
1J Leistung:
+1,479%
1-Tages-Spanne:
$20.62
$22.20
1-Wochen-Bereich:
$18.93
$22.20
52-Wochen-Spanne:
$1.03
$22.20
Tango Therapeutics Inc Stock (TNGX) Company Profile
Firmenname
Tango Therapeutics Inc
Sektor
Branche
Telefon
(857) 320-4900
Adresse
201 BROOKLINE AVENUE, BOSTON
Compare TNGX vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
21.63 | 3.09B | 62.38M | -101.59M | -139.93M | -0.8644 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-23 | Eingeleitet | Mizuho | Outperform |
| 2025-11-18 | Eingeleitet | Wolfe Research | Peer Perform |
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-17 | Eingeleitet | Jefferies | Buy |
| 2024-04-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-08 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-20 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten
Tango Therapeutics is the best performing healthcare stock in March - MSN
Insider Selling: Tango Therapeutics (NASDAQ:TNGX) Insider Sells 27,000 Shares of Stock - MarketBeat
Tango Therapeutics stock hits all-time high at 21.84 USD By Investing.com - Investing.com Canada
Tango Therapeutics president sells $572k in shares By Investing.com - Investing.com Canada
Tango Therapeutics (NASDAQ: TNGX) president sells 27,000 shares - Stock Titan
Tango a new Buy at Canaccord Genuity on 2026 catalysts - MSN
Tango stock is a new Buy at Canaccord Genuity (TNGX:NASDAQ) - Seeking Alpha
Tango Therapeutics (NASDAQ:TNGX) Reaches New 12-Month HighHere's Why - MarketBeat
Canaccord Genuity Group Begins Coverage on Tango Therapeutics (NASDAQ:TNGX) - MarketBeat
CCORF Initiates Tango Therapeutics(TNGX.US) With Buy Rating, Announces Target Price $30 - Moomoo
Tudor Investment Corp ET AL Takes $450,000 Position in Tango Therapeutics, Inc. $TNGX - marketbeat.com
Is Tango Therapeutics Inc a strong candidate for buy and hold2026 Chart Watch & AI Based Trade Execution Alerts - baoquankhu1.vn
Decliners Report: Can Tango Therapeutics Inc be recession proof2026 Fed Impact & Free Reliable Trade Execution Plans - baoquankhu1.vn
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
TNGX Stock Price, Quote & Chart | TANGO THERAPEUTICS INC (NASDAQ:TNGX) - ChartMill
Tango Therapeutics (TNGX) price target increased by 32.09% to 20.06 - MSN
Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge - AOL.com
Tango Therapeutics is the best performing healthcare stock in March (XLV:NYSEARCA) - Seeking Alpha
Evaluating Tango Therapeutics (TNGX) Rich Valuation After Recent Share Price Momentum - Yahoo Finance
Geopolitics Watch: Can Tango Therapeutics Inc ride the EV waveTrade Performance Summary & Community Verified Trade Alerts - baoquankhu1.vn
Adam Crystal Sells 12,000 Shares of Tango Therapeutics (NASDAQ:TNGX) Stock - MarketBeat
VIX Spike: Is Tango Therapeutics Inc a strong candidate for buy and holdSwing Trade & Risk Managed Investment Signals - baoquankhu1.vn
Tango Therapeutics president sells $241k in shares By Investing.com - Investing.com South Africa
Tango Therapeutics president sells $241k in shares - Investing.com
Tango Therapeutics (TNGX) R&D chief exercises options, sells 12,000 shares - Stock Titan
Momentum Shift: Is Tango Therapeutics Inc stock good for income investors2026 Volume & Consistent Profit Alerts - baoquankhu1.vn
TNGXTango Therapeutics Inc Stock Price and Quote - Finviz
Tango Therapeutics (NASDAQ: TNGX) — Vanguard reports 0 shares after realignment - Stock Titan
B. Riley Securities Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Raises Target Price to $21 - Moomoo
B. Riley Raises Price Target on Tango Therapeutics to $21 From $14, Keeps Buy Rating - MarketScreener
This Stock Is Up 1,229% in Just the Past Year, But Don’t Bet Your Retirement Money on It - inkl
TNGX: 93,000 shares from option exercise; Adam Crystal prior 10b5-1 sales (TNGX) - Stock Titan
Tango Therapeutics (NASDAQ:TNGX) Stock Price Up 9.3%Still a Buy? - MarketBeat
Tango Therapeutics Ignites: 11% Surge to Historic Highs Signals Biotech Power Play - Bitget
TNGX stock hits record high on inking collaboration deal with ERAS - MSN
Tango Therapeutics stock hits all-time high at 19.83 USD By Investing.com - Investing.com Canada
Tango Therapeutics stock hits all-time high at 19.83 USD - Investing.com
Tango Therapeutics (TNGX) to Release Quarterly Earnings on Monday - marketbeat.com
Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates - MSN
Trading Recap: How does Tango Therapeutics Inc correlate with Nasdaq2026 Analyst Calls & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Wall Street Zen Downgrades Tango Therapeutics (NASDAQ:TNGX) to Sell - MarketBeat
Tango Therapeutics (TNGX) sees cautious analyst optimism following earnings - msn.com
Aug Levels: Will Tango Therapeutics Inc benefit from rising consumer demandSwing Trade & Real-Time Sentiment Analysis - baoquankhu1.vn
TNGX Technical Analysis & Stock Price Forecast - Intellectia AI
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology - GlobeNewswire Inc.
Tango TherapeuticsFinancial Details - Crunchbase
Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.49%
1.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):